Home › BIO Study looks at venture funding for therapeutic innovation.
 

Keywords :   


BIO Study looks at venture funding for therapeutic innovation.

2015-02-13 14:30:24| Industrial Newsroom - All News for Today

BIO released study on venture financing broken down by disease area and novelty of research from 2004–2013. Study found that 78% of U.S. venture investment for therapeutics went toward novel drug R&D, suggesting innovation is core priority for investors. Disease areas affecting large populations – Diabetes, Psychiatry, Gastrointestinal, Respiratory, and Cardiovascular – have seen decline in novel drug R&D venture funding, while rare disease funding has seen large increase over past decade.

Tags: study bio funding innovation

Category:Industrial Goods and Services

Latest from this category

All news
17.05Next MANAchat Series Scheduled for the Week of June 10
15.05Relationship Reviews Strengthening the Partnership Between Manufacturer and Rep
14.05Consolidated Financial Statements for the twelve-month period ended March 31, 2024
14.05Actions to Implement Management that is Conscious of Cost of Capital and Stock Price
Industrial Goods and Services »
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
More »